Posted in | News | Quantum Dots | Nanobusiness

Nanoco Signs Follow-On Joint Development Agreement with Osram for Cadmium-Free Quantum Dots Technology

Nanoco Group plc, a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that it has signed a follow-on joint development agreement with Osram, one of the world’s largest lighting companies, in connection with the use of Nanoco cadmium-free quantum dots in general lighting.

Quantum dots open up new potential for LED lighting – which currently lacks the same warmth and color performance of an incandescent bulb – and have the capacity to appeal to a new set of buyers who want the efficiency and economy of the LED, as well as the “effect” of natural light. To date, the use of quantum dots in lighting was hindered by the fact that the technology contained cadmium, a highly-regulated and toxic heavy metal. Nanoco’s technology, made without cadmium or any heavy metal, offers a sustainable solution.

“We’re delighted to sign this latest joint development agreement with Osram and believe in the great potential of our quantum dot technology in general lighting,” said Michael Edelman, CEO, Nanoco. “Since singing our initial development agreement with Osram, we’ve made technical progress towards the development of an LED incorporating cadmium-free quantum dots and offering substantially improved color performance.”

Nanoco has been working with Osram since 2011 with the objective of delivering LED lighting with superior performance characteristics. Considerable technical progress has been made to date in optimizing the method for incorporating Nanoco’s cadmium-free quantum dots with blue LEDs. This latest, 12-month agreement with Osram will further product development.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.